For NYC leaders and clinical teams, targeted training such as Nucamp’s 15-week AI Essentials for Work bootcamp provides the practical prompt-writing and workflow integration skills needed to turn those research gains into on-the-ground savings and fewer denials (Nucamp AI Essentials for Work syllabus<\/a>).<\/p>\n \u201cOur findings provide a road map for health care systems to integrate advanced AI tools to automate tasks efficiently, potentially cutting costs for API calls for LLMs up to 17-fold and ensuring stable performance under heavy workloads.\u201d – Girish N. Nadkarni, MD, MPH<\/p><\/blockquote>\n Table of Contents<\/p>\n High-impact administrative targets: RCM and prior authorization in New York City(Up)<\/p>\n High-impact administrative wins in New York City come from automating revenue-cycle management (RCM) front- and mid\u2011cycle tasks – insurance eligibility checks, prior\u2011authorization document collection and status checks, claim scrubbing, and denial workflows – which shrink error-driven denials, accelerate cash flow, and free clinicians from billing chores; national scans show nearly half of hospitals are already using AI in RCM (AHA market scan: AI for revenue-cycle management (RCM)<\/a>).<\/p>\n Targeted pilots matter: experts estimate prior\u2011authorization automation alone can reclaim up to 33,000 RCM staff\u2011hours, and combining automation with selective outsourcing has been shown to cut billing staffing costs dramatically – one NYC\u2011focused provider report cites up to 70% savings – so a concrete first step is a short pilot that measures denial rates, days sales outstanding, and hours recovered before scaling (RCM automation benefits, challenges, and use cases (Auxis)<\/a>; Outsourcing revenue cycle management in NYC hospitals: efficiency and ROI<\/a>).<\/p>\n Clinical AI that improves diagnosis and reduces costs in New York City(Up)<\/p>\n Clinical AI is delivering measurable diagnostic gains in New York City when paired with bedside workflows: Mount Sinai’s delirium\u2011risk model, trained on more than 32,000 inpatient records and woven into clinical operations, boosted monthly detection from 4.4% to 17.2% – a fourfold increase that enabled earlier specialist assessment, safer prescribing with lower sedative doses, and faster treatment of a condition that otherwise prolongs stays and raises mortality risk (Mount Sinai AI delirium model improves delirium prediction study<\/a>).<\/p>\n Parallel investments in computational pathology and applications like NutriScan highlight how AI can surface malnutrition and molecular markers earlier, shifting scarce clinician time from manual screening to intervention.<\/p>\n These wins require safeguards: Mount Sinai analyses show LLMs can exhibit sociodemographic bias and hallucinate clinical recommendations, so prompt design, human oversight, and fairness testing must accompany any diagnostic rollout to avoid unequal care (Mount Sinai study on LLM bias in medicine<\/a>).<\/p>\n The bottom line for NYC health systems: validated clinical models that integrate with workflows can find more true positives at the bedside, shorten the path to treatment, and reduce avoidable costs across diverse, high\u2011volume hospitals.<\/p>\n \u201cOur model isn’t about replacing doctors – it’s about giving them a powerful tool to streamline their work,\u201d – Joseph Friedman, MD<\/p><\/blockquote>\n Generative AI and LLM strategies for NYC health systems(Up)<\/p>\n New York City health systems moving from pilots to scale should pair guarded, private LLM environments with clear governance, clinician training, and realistic use-cases: NYU Langone’s Predictive Analytics & Artificial Intelligence group (DAAIT) runs a managed generative\u2011AI program that vets commercial tools, prioritizes access for research or innovation projects, and requires data\u2011use agreements while explicitly banning PHI or clinical documentation in public models (NYU Langone DAAIT Predictive Analytics & Artificial Intelligence program<\/a>); a 2025 JAMIA report documents system\u2011wide deployment of a private GenAI instance at NYU Langone, underscoring that a centrally governed, secure instance can enable broad clinician access without exposing sensitive records (JAMIA 2025 study: Health system\u2011wide access to generative AI at NYU Langone<\/a>).<\/p>\n Risk\u2011mitigation strategies shown in the literature include using private or open\u2011source models, synthetic data for development, and tight legal agreements with vendors to preserve institutional value and patient privacy – practical steps that turn generative AI from a risky experiment into an operational tool that shortens documentation time, surfaces actionable risk predictions, and protects patient trust (Generative AI in Health Care: privacy and security concerns – Gastroenterology Advisor<\/a>).<\/p>\n \u201cIt’s both an exciting time and a scary time, with the advances in AI that have come and are coming.\u201d<\/p><\/blockquote>\n Autonomous care and self-service platforms in New York City(Up)<\/p>\n Autonomous, self\u2011service platforms like Forward’s CarePod were pitched as a way to embed preventative screens and basic diagnostics into New York life – installed in malls, gyms and offices and offering on\u2011demand vitals, body scans, throat swabs and needleless blood collection for a membership starting at $99\/month – backed by a $100M growth round to scale nationwide (TechCrunch coverage of Forward CarePod launch<\/a>).<\/p>\n The promise for NYC was clear: move routine, high\u2011volume screening out of clinics and into places people already visit, freeing clinician time and improving access.<\/p>\n The hard lessons are also local: deployment stalled, several markets (including New York) saw fewer pods than planned, and a November 2024 shutdown highlighted operational and regulatory pitfalls – failed automated blood draws, lab pullbacks, and building\u2011approval hurdles that left some tests and locations unrealized – showing that convenience alone doesn’t substitute for validated workflows and tight clinical oversight (Business Insider report on Forward CarePod shutdown<\/a>).<\/p>\n For NYC health systems and startups, the takeaway is practical: pilot autonomous kiosks with clear safety metrics, integration to local labs and clinicians, and contingency plans before broad rollouts.<\/p>\n \u201cIf Elon has the self-driving car, well, this is the autonomous doctor’s office,\u201d – Adrian Aoun<\/p><\/blockquote>\n Operational playbook: implementing AI safely in New York City healthcare(Up)<\/p>\n Turn AI pilots into reliable operations in New York City by sequencing three concrete steps: (1) embed worker-led governance to surface frontline risks and design practical controls – Platform Co\u2011op’s proposed Platform Co\u2011op AI Labor Council pilot<\/a> recommends a one\u2011year run with monthly meetings of ~10\u201315 workers to vet emerging harms and negotiate safeguards; (2) mandate local validation and continuous monitoring so models reflect NYC’s diverse patient mix – Epic’s upcoming \u201cAI trust and assurance\u201d suite automates data mapping and demographic dashboards to test models on local workflows, an approach UCSD used when its sepsis model drove a 17% mortality reduction; and (3) align deployments to shared standards by adopting industry frameworks like the Coalition for Health AI (CHAI) standards framework<\/a> to bake fairness, testing, and lifecycle controls into procurement and vendor contracts.<\/p>\n Operational metrics should be simple and local – model drift, demographic performance slices, clinician time saved, and adverse\u2011event counts – so NYC systems can scale with confidence while protecting patients and staff.<\/p>\n \u201cWe’ll provide health systems with the ability to combine their local information about the outcomes around their workflows, alongside the information about the AI models that they’re using, and they will be able to use that both for evaluation and then importantly, ongoing monitoring of those models in their local contexts.\u201d – Seth Hain, Epic<\/p><\/blockquote>\n Barriers, limits, and policy considerations for New York City(Up)<\/p>\n New York City health systems must navigate a crowded risk landscape before scaling AI: privacy and data\u2011security pitfalls and the need for explainability, fairness, and sustainability are already front\u2011and\u2011center in local counsel briefings (NYC Bar overview of AI in health care laws and policy<\/a>), while a 2025 New York State audit found no effective statewide AI governance and noted that sampled agencies \u201cdid not develop specific procedures to test AI outputs for accuracy or bias,\u201d leaving institutions exposed to unseen errors and disparate impacts (New York State Comptroller audit of AI governance (April 2025)<\/a>).<\/p>\n Legal uncertainty adds friction: international and comparative analyses warn that training data gaps, re\u2011identification risk, and unresolved liability models make deployment legally fragile without strong contracts and board\u2011level oversight (IBA analysis of legal obstacles to healthcare AI<\/a>).<\/p>\n The so\u2011what: NYC hospitals that postpone governance, bias testing, and workforce training risk regulatory penalties and patient harm – the audit specifically recommends revising the State’s AI policy and delivering coordinated training to close that gap.<\/p>\n \u201cWe haven’t had legislative tools or policymaking tools or anything to fight back. This is finally a tool I can use to fight back.\u201d – Dr. Azlan Tariq<\/p><\/blockquote>\n Concrete NYC case studies and data-driven results(Up)<\/p>\n Concrete New York City results show AI delivering measurable clinical and operational gains when paired with workflow integration and safety controls: Mount Sinai’s delirium\u2011risk model, deployed across more than 32,000 inpatient admissions, quadrupled monthly detection from 4.4% to 17.2%, enabling earlier specialist assessment and safer prescribing with lower sedative doses (Mount Sinai delirium risk model improves detection and prescribing<\/a>); a real\u2011time pathology \u201csilent trial\u201d demonstrated that an AI model can flag EGFR mutations from routine slides and potentially cut rapid genetic tests by more than 40%, preserving tissue for comprehensive sequencing and speeding precision therapy choices (computational pathology study showing EGFR mutation detection<\/a>).<\/p>\n Equally important: stress\u2011tests of generative chatbots found widespread hallucination risk but showed a one\u2011line warning prompt reduced those errors nearly in half – an operationally simple safeguard before clinical use (Mount Sinai chatbot study on hallucination reduction with warning prompts<\/a>).<\/p>\n The so\u2011what: targeted models integrated with clinical teams can find more true positives, preserve scarce diagnostic resources, and deliver faster, safer care at scale in NYC hospitals.<\/p>\n \u201cWhat we saw across the board is that AI chatbots can be easily misled by false medical details… The encouraging part is that a simple, one-line warning added to the prompt cut those hallucinations dramatically, showing that small safeguards can make a big difference.\u201d – Mahmud Omar, MD<\/p><\/blockquote>\n Next steps for NYC healthcare leaders and startups(Up)<\/p>\n Next steps for NYC healthcare leaders and startups: start with narrow, measurable pilots – automate eligibility checks, prior\u2011authorization status pulls, and claim scrubbing while tracking denial rates, days\u2011sales\u2011outstanding and staff hours recovered – and evaluate selective outsourcing where appropriate (see Outsourcing revenue cycle management in New York City – staffing savings and 24\/7 support: Outsourcing revenue cycle management in New York City – staffing savings and 24\/7 support<\/a>) to free clinicians for care; run local validation and fairness tests on any model before clinical use, deploy private LLM instances or synthetic data for development, and require tight vendor SLAs and legal protections; and invest in practical workforce uplift so operational teams own prompt design, model monitoring, and claims workflows – Nucamp AI Essentials for Work bootcamp (15 weeks)<\/a> teaches prompt skills and applied AI workflows that translate pilot gains into sustained improvements.<\/p>\n These steps turn one\u2011off experiments into repeatable savings and safer, faster revenue cycles across diverse NYC settings.<\/p>\n \u201cpatients are being checked in at a faster and more efficient rate,\u201d<\/p><\/blockquote>\n Frequently Asked Questions(Up)<\/p>\n How is AI helping NYC health systems cut costs and improve efficiency?<\/p>\n AI is reducing administrative waste and accelerating patient-facing workflows in NYC by automating revenue-cycle tasks (eligibility checks, prior authorization, claim scrubbing, appeals), grouping clinical tasks for LLMs to reduce API costs (research shows up to 17-fold cost reduction for some LLM task groupings), and deploying validated clinical models (for example, Mount Sinai’s delirium-risk model increased monthly detection from 4.4% to 17.2%). Targets for pilots include denial rates, days-sales-outstanding, and recovered staff hours.<\/p>\n Which administrative areas show the biggest ROI from AI in New York City hospitals?<\/p>\n Revenue-cycle management (RCM) and prior-authorization workflows show the largest near-term ROI. National scans report roughly 46% of hospitals using AI in RCM. Prior-authorization automation alone can reclaim large numbers of staff hours (estimates up to ~33,000 RCM staff-hours in some studies), and combining automation with selective outsourcing has produced reported billing staffing cost reductions (some NYC provider reports cite up to 70% savings).<\/p>\n What clinical AI results have NYC health systems demonstrated and what safeguards are required?<\/p>\n Validated clinical models integrated with bedside workflows have shown measurable gains – Mount Sinai’s delirium model analyzed >32,000 inpatient records and increased monthly detection from 4.4% to 17.2% (~4x), enabling earlier intervention and safer prescribing. Computational pathology work suggests >40% potential reductions in some rapid genetic tests. Safeguards required include prompt design, human oversight, fairness and bias testing, local validation, continuous monitoring, and policies to mitigate LLM hallucinations and sociodemographic bias.<\/p>\n How should NYC health systems scale generative AI and LLMs safely?<\/p>\n Scale using guarded private LLM environments or vetted open-source models, paired with clear governance, clinician training, data-use agreements, and bans on PHI in public models. Examples include NYU Langone’s centrally governed private GenAI instance and managed program that vets tools and requires legal safeguards. Risk-mitigation strategies include synthetic data for development, tight vendor contracts, local validation, ongoing monitoring, and simple operational safeguards (e.g., one-line warning prompts to reduce chatbot hallucinations).<\/p>\n What practical next steps and workforce training should NYC leaders take to translate AI pilots into sustained savings?<\/p>\n Start with narrow, measurable pilots (automate eligibility checks, prior-authorization pulls, claim scrubbing), track denial rates, days-sales-outstanding, and staff hours recovered, and evaluate selective outsourcing where appropriate. Require local validation, fairness testing, private LLMs or synthetic data for development, and strong vendor SLAs. Invest in practical upskilling – courses like Nucamp’s 15-week AI Essentials for Work bootcamp teach prompt-writing and workflow integration – so operational teams can own prompt design, model monitoring, and claims workflows to turn pilot gains into lasting efficiency.<\/p>\n You may be interested in the following topics as well: N <\/p>\n Ludovic (Ludo) Fourrage is an education industry veteran, named in 2017 as a Learning Technology Leader by Training Magazine. Before founding Nucamp, Ludo spent 18 years at Microsoft where he led innovation in the learning space. As the Senior Director of Digital Learning at this same company, Ludo led the development of the first of its kind ‘YouTube for the Enterprise’. More recently, he delivered one of the most successful Corporate MOOC programs in partnership with top business schools and consulting organizations, i.e. INSEAD, Wharton, London Business School, and Accenture, to name a few. \u200bWith the belief that the right education for everyone is an achievable goal, Ludo leads the nucamp team in the quest to make quality education accessible<\/p>\n","protected":false},"excerpt":{"rendered":"Too Long; Didn’t Read: AI pilots and upskilling in NYC health systems cut costs and speed care: LLM…\n","protected":false},"author":3,"featured_media":171297,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5122],"tags":[5229,405,403,5226,5225,5228,5227,67,586,132,5230,68,2969],"class_list":{"0":"post-171296","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-new-york","8":"tag-america","9":"tag-new-york","10":"tag-new-york-city","11":"tag-newyork","12":"tag-newyorkcity","13":"tag-ny","14":"tag-nyc","15":"tag-united-states","16":"tag-united-states-of-america","17":"tag-unitedstates","18":"tag-unitedstatesofamerica","19":"tag-us","20":"tag-usa"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115082857244077767","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/171296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=171296"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/171296\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/171297"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=171296"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=171296"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=171296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
MetricResult<\/tr>\n \n Patients evaluated<\/td>\n >32,000 (The Mount Sinai Hospital)<\/td>\n<\/tr>\n \n Delirium detection (pre\u2011deployment)<\/td>\n 4.4% monthly<\/td>\n<\/tr>\n \n Delirium detection (post\u2011deployment)<\/td>\n 17.2% monthly<\/td>\n<\/tr>\n \n Relative increase<\/td>\n ~400%<\/td>\n<\/tr>\n StudyDetail<\/tr>\n \n Health system\u2011wide GenAI at NYU Langone<\/td>\n J Am Med Inform Assoc, 2025; PMID: 39584477<\/td>\n<\/tr>\n MetricDetail<\/tr>\n \n Membership price<\/td>\n $99\/month<\/td>\n<\/tr>\n \n Series E funding (for CarePods)<\/td>\n $100 million<\/td>\n<\/tr>\n \n Planned expansion<\/td>\n Includes New York City (malls, gyms, offices)<\/td>\n<\/tr>\n \n Outcome reported Nov 2024<\/td>\n Company shutdown; limited CarePod deployments<\/td>\n<\/tr>\n Operational ElementConcrete Detail<\/tr>\n \n Worker governance<\/td>\n One\u2011year AI Labor Council pilot; monthly meetings; 10\u201315 workers<\/td>\n<\/tr>\n \n Validation & monitoring<\/td>\n Epic AI trust suite: automated mapping, demographic dashboards, ongoing monitoring<\/td>\n<\/tr>\n \n Standards<\/td>\n Adopt CHAI draft framework across development lifecycle<\/td>\n<\/tr>\n BarrierPolicy \/ Operational Response<\/tr>\n \n Weak statewide governance<\/td>\n Amend NYS AI policy; create agency procedures and coordinated training (OSC recommendation)<\/td>\n<\/tr>\n \n Privacy & security risks<\/td>\n Limit PHI in public LLMs; tighten data\u2011use agreements and technical safeguards<\/td>\n<\/tr>\n \n Bias, accuracy, liability<\/td>\n Mandate local validation, routine bias testing, and clear vendor liability terms<\/td>\n<\/tr>\n MetricResult<\/tr>\n \n Inpatient records analyzed<\/td>\n >32,000 (Mount Sinai)<\/td>\n<\/tr>\n \n Delirium detection (pre \u2192 post)<\/td>\n 4.4% \u2192 17.2% monthly<\/td>\n<\/tr>\n \n Potential reduction in rapid genetic tests<\/td>\n >40% (computational pathology)<\/td>\n<\/tr>\n \n Chatbot hallucination reduction<\/td>\n Errors cut nearly in half with one\u2011line warning<\/td>\n<\/tr>\n
![\"Ludo](\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/08\/ludo.webp.webp\")
N <\/p>\n